The Will Norman Nurse Webinar #2 was delivered on 20th March for Australia and New Zealand audiences, and 19th March for the UK, bringing together nurses internationally for a comprehensive and patient centred learning experience.
Hosted by NeuroEndocrine Cancer Australia CEO Meredith Cummins, the webinar featured a powerful patient representative story, providing first-hand insight into living with neuroendocrine cancer (NETs), carcinoid syndrome, and carcinoid heart disease.
Presentations were delivered by a multidisciplinary panel including Nikie Jervis, Avril Hull, Kahlia Wolsley, Steph Lindores, and Jonathan Sen.
With 24 live attendees and many more registered to access the recording, the session covered key topics including:
- An overview of NETs
- Treatment pathways, from watch-and-wait approaches to medical and surgical options, including PRRT (with case study)
- Carcinoid syndrome and its complications, including carcinoid crisis and carcinoid heart disease
- Nursing approaches to supporting patients living with carcinoid syndrome
This webinar highlighted the importance of ongoing nurse education to improve outcomes and support for patients living with NETs.
Thank you to Novartis for sponsoring this webinar, and to the Norman Family for their generous support of this webinar series, your commitment is making a meaningful difference in education and care for the NET community.
